peripheral blood; plasma
-
not specified
Bioinformatics Analysis; RT-qPCR; Clinical Sample Validation; ROC Analysis
A component of a 4-ncRNA plasma biomarker panel that distinguishes malignant from benign GGNs with AUC up to 0.88 in external validation.
cirUBXN7 is up-regulated in peripheral blood/plasma of patients with malignant pulmonary GGNs compared with benign GGNs and healthy controls. It was selected as one of four ncRNAs in a logistic-regression biomarker panel that improves diagnostic discrimination of malignant vs benign GGNs and was validated in internal and external cohorts.
0.459
Biomarkers via liquid biopsy for distinguishing malignant from benign pulmonary ground-glass nodule.
combined biological and clinical study